Aethon Therapeutics

Aethon Therapeutics

Biotechnology Research

New York, NY 1,583 followers

Creating neoantigens by design -- to transform cancer treatments into cures

About us

Aethon takes a novel approach to fighting cancer, creating custom antibody therapeutics that unite immunotherapy and targeted therapy.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
New York, NY
Type
Privately Held
Founded
2022
Specialties
cancer drugs, immuno-oncology, biomedical research, and drug development

Locations

Employees at Aethon Therapeutics

Updates

Similar pages

Funding

Aethon Therapeutics 1 total round

Last Round

Series A

US$ 30.0M

See more info on crunchbase